The Hologic Global Access Initiative was launched at the International AIDS Society Conference in July 2018, setting a new standard for affordable and transparent pricing. The breakthrough agreement sets out one low price per-patient test including the costs of delivery, maintenance, and service as well as all consumables.
Under the agreement, MedAccess will underwrite the risk of supplying the tests in uncertain markets, allowing Hologic to introduce viral load testing to national government testing programmes at a significantly reduced rate. It is anticipated that the agreement will save public sector purchasers over $50m over the next four years and beyond. At least five countries in sub-Saharan Africa are expected to introduce this technology in 2018.
Read: CDC GROUP’S ARTICLE
Rt Hon Alistair Burt, Minister of State at DFID said:
New support for UNICEF to secure vital COVID-19 medical products, including diagnostic tests and clinical management supplies, for low- and middle-income countries.
MedAccess is pleased to announce the appointment of Hema Srinivasan as the social finance company’s new Chief Access Officer. Hema will take up her new role in March 2020.
The price of new BASF Interceptor® G2 anti-mosquito bed nets will be reduced by 40% for underserved communities thanks to a new MedAccess partnership